pharmaphorum

JUNE 8, 2021

At the same time, lots of people with experience at multinational pharmaceutical companies have chosen to return home. All these factors will support the growth of in-house R&D-driven pharmaceutical companies and bring more innovative drugs to Asian markets.”.

Chemotherapy 105

Chemotherapy Pharmaceutical Companies Pharmaceutical Companies Immunization 105

pharmaphorum

DECEMBER 28, 2022

So, how do smaller pharmaceutical companies at the cutting edge get ready for their acquisition milestone, so they maximise their value and attractiveness? Any purchasing company would ideally like to integrate their acquisitions into their company seamlessly. She joined NSF in 2017.

Documentation 117

Documentation Pharmaceutical Companies Pharmaceutical Companies FDA 117

Pharmaceutical Technology

MARCH 22, 2023

The pharmaceutical industry began using radio frequency identification (RFID) tags in the early 2000s. Pfizer was the first to use the tech, adding RFID tags to track a Viagra (sildenafil) shipment circa 2006. As computing has developed in the past decade, so has the potential to store and use information in the cloud.

Labelling 105

Labelling Data Entry Communication FDA 105

pharmaphorum

SEPTEMBER 18, 2020

But although it was dubbed a “dangerous game”, some companies came out on top… On 6th April 1999, two companies with similar science-based cultures and a shared vision of the pharmaceutical industry came together to form what’s now considered as one of the top ten pharma companies in the world: AstraZeneca.

Vaccines 116

Vaccines Pharmaceutical Companies Pharmaceutical Companies FDA 116

PharmaShots

APRIL 13, 2023

model is a holistic approach to incorporate the same strategy to life science and pharmaceutical companies. A globally fast-growing, and largest pharmaceutical company in the world was created through a merger between Pfizer and Pharmacia. by the sales of Humira 2006 Johnson & Johnson recorded global sales of $53.3B

Vaccines 40

Vaccines Pharmaceutical Companies Pharmaceutical Companies Labelling 40

pharmaphorum

NOVEMBER 22, 2021

In late 2006, BRAVEMIND was tested in San Diego, California, at the Naval Medical Center and Camp Pendleton, and good clinical data was obtained in the initial open clinical trials. Other groups started to adopt the platform, which led to more research as to its clinical efficacy. .”

Pharmaceutical Companies 115

Pharmaceutical Companies Pharmaceutical Companies FDA 115

pharmaphorum

JANUARY 28, 2021

Despite huge progress over the last decade, patient involvement in research is still largely in the hands of the pharmaceutical companies. He led a small group of Parkinson’s disease (PD) researchers for years before being diagnosed with the condition himself in 2006, three years after retiring from academia.

Pharmaceutical Companies 70

Pharmaceutical Companies Pharmaceutical Companies 70

Pharmaceutical Technology

OCTOBER 5, 2022

Ferry describes a popular solution among pharmaceutical companies. Some companies try to separate the clinical educational programs from their sales programs, and the speaker programs are run through the clinical education programs. The company currently has three MS drugs in its pipeline.

Documentation 59

Documentation Pharmaceutical Companies Pharmaceutical Companies FDA 59

PQA

SEPTEMBER 19, 2024

With over 200 members, including pharmaceutical companies, MTM organizations, health plans, pharmacies, and academia, PQA ensures diverse voices are heard. Since its inception in 2006, PQA has had a rich history. PQA is unique in this space. Additionally, PQA’s multi-stakeholder perspective is vital.

Pharmaceutical Companies 40

Pharmaceutical Companies Pharmaceutical Companies Patient Care 40

Omnicell

JANUARY 10, 2023

There was bipartisan support for the program at the hearing and support for measures such as requiring pharmaceutical companies to publish their prices in a password protected site on HRSA's website. 2006: Congress passed, and President George W.

Hospitals 96

Hospitals Insurance Omnicell Documentation 96

pharmaphorum

DECEMBER 21, 2021

There has been progress in this area in recent years, with both the European Union (EU), through Regulation (EC) No 1901/2006 , and the US, through the Orphan Drug Act , enacting legislation to encourage the development of therapies for Rare Diseases. Headway being made.

Pharmaceutical Companies 97

Pharmaceutical Companies Pharmaceutical Companies Hospitals FDA 97

PharmaShots

MARCH 29, 2023

Shots: Drug patent expiry is when a patent granted to a pharmaceutical company for a particular drug expires, allowing other companies to produce and sell generic versions Like every other utility patent, pharmaceuticals also get market exclusivity of 20 years.

FDA 49

FDA Chemotherapy Immunization Dosage 49

Pharmaceutical Technology

JULY 10, 2008

When TS Eliot said humankind cannot stand very much reality, he obviously did not consider the virtual kind which is now heralded as the key for curing and preventing disease and picked as the potential lifeline for R&D in the pharmaceutical industry.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies Communication 52

Pharmaceutical Technology

AUGUST 26, 2008

It was once derided as the stuff of science fiction, but in recent years, biotechnology has emerged as an important growth area in pharmaceuticals. As understanding of biological systems has forged ahead, pharmaceutical companies have made increasing use of biotechnology in discovering and manufacturing new medicines.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies Vaccines Immunization 52

pharmaphorum

DECEMBER 2, 2020

One thing that highlighted this changed focus was the appointment of Kindler as CEO in 2006. In 2014 the company made an offer of around $100 billion to acquire UK firm AstraZeneca (which at the time was going through a rough patch ).

Compounding 128

Compounding Vaccines Pharmaceutical Companies Pharmaceutical Companies 128

Pharmaceutical Technology

OCTOBER 5, 2008

“The business integration from 2005 to 2007 of the two separate companies to form the joint Daiichi Sankyo created one of Japan’s biggest pharmaceutical companies.” “Local generic companies such as Ranbaxy and DRL have expanded through acquisition in Western markets aggressively in 2006.”

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies Labelling 52

Pharmaceutical Technology

JULY 23, 2008

The world’s biggest pharmaceutical company Pfizer announced in June 2008 that it would be putting its “full scope and scale” behind a push into the cancer market. “Companies used to be universally protected by patents but there is a pathway to approval opening up for biosimilar legislation. .”

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies Compounding Chemotherapy 52

ISPE

MARCH 7, 2023

A collaborative mindset must prevail between pharmaceutical companies, suppliers, and regulators and include strategic partnerships that go beyond the pharmaceutical sector so we can move together to a more sustainable future. The risks are equally applicable to both privately owned and publicly traded companies.

Health and Personal Care Stores 52

Health and Personal Care Stores Pharmaceutical Companies Pharmaceutical Companies Communication 52

PharmaShots

FEBRUARY 21, 2023

The company is evaluating Iomab-B in a P-III clinical trial (SIERRA) in patients with relapsed or refractory acute myeloid leukemia (AML). The company’s radiopharma pipeline is focused on indications including Prostate, Kidney, Brain, Blood, and Bone marrow cancers.

FDA 56

FDA Dosage Pharmaceutical Companies Pharmaceutical Companies 56

Pharma Marketing Network

JUNE 11, 2020

John Mack (PG): So, when I got laid off and as a consultant, I was working for a consulting company, helping them do websites for pharmaceutical companies in the.com bust, you know, a lot of people got laid off. It wasn’t just pharmaceutical companies and others. John Mack (PG): I think 2006 to 2012.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies Communication FDA 52

PharmaShots

FEBRUARY 27, 2023

The speakers shared their views on the topic: Dr. Jagadeesh Babu Rangisetty- “COVID has taught us so many things and the pharmaceutical company has gone through a lot of challenges and at the same time opportunities. According to me the main issue faced during the pandemic was the supply chain of pharmaceuticals.

Packaging 40

Packaging Hospitals FDA Pharmaceutical Companies 40